https://www.youtube.com/watch?v=DKLLKP7pk0o
On March 6, when Gilead Sciences announced clinical trials of their anti-viral medication Remdesivir, I bought shares in their stock (and yes, it is up). Coincidentally, one of my children had an assignment at University to model how the medication (Remdesivir) binds to SARS-CoV-2.
No comments:
Post a Comment